Detailed Information on Publication Record
2021
Oral Candidiasis of COVID‐19 Patients: Case Report and Review of Evidence
RIAD, Abanoub, Esraa GOMAA, Barbora HOCKOVA and Miloslav KLUGARBasic information
Original name
Oral Candidiasis of COVID‐19 Patients: Case Report and Review of Evidence
Authors
RIAD, Abanoub (818 Egypt, guarantor, belonging to the institution), Esraa GOMAA (818 Egypt), Barbora HOCKOVA (203 Czech Republic) and Miloslav KLUGAR (203 Czech Republic, belonging to the institution)
Edition
Journal of Cosmetic Dermatology, Hoboken, Wiley, 2021, 1473-2130
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30216 Dermatology and venereal diseases
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 2.189
RIV identification code
RIV/00216224:14110/21:00121232
Organization unit
Faculty of Medicine
UT WoS
000630882200001
Keywords in English
Oral Candidiasis; COVID‐19
Tags
International impact, Reviewed
Změněno: 7/6/2021 14:17, Mgr. Tereza Miškechová
Abstract
V originále
The immune dysregulation triggered by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection has been hypothesised as a causal pathway for the increasingly reported oral manifestations associated with coronavirus diseases (COVID‐19) especially the ones of fungal origin.1–3 As a result of this, we aim to report according to the CARE guidelines, three COVID‐19 cases who sought teleconsultations from our private practice (Cairo, Egypt) from July to September 2020. In addition, we have performed a literature search in Ovid MEDLINE®, EMBASE, Cochrane Library, and Epistemonikos from inception until November 30th, 2020 with a combination of keywords (COVID‐19 OR SARS‐CoV‐2) AND oral candidiasis.
Links
LTC20031, research and development project |
| ||
MUNI/A/1608/2020, interní kód MU |
| ||
MUNI/IGA/1543/2020, interní kód MU |
|